Title : Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.

Pub. Date : 2013 Dec

PMID : 24130050






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma. Tunicamycin thymoma viral proto-oncogene 1 Mus musculus
2 Tunicamycin combined with cisplatin (CDDP) inhibited proliferating cell nuclear antigen (PCNA) expression and increased the cleavage of PARP; this effect was partially rescued by the overexpression of ABCG2 or Akt-myr. Tunicamycin thymoma viral proto-oncogene 1 Mus musculus
3 In summary, our results suggest that tunicamycin may reverse the drug resistance and improve the efficacy of combination treatments for hepatocellular carcinomas by targeting the DPAGT1/Akt/ABCG2 pathway. Tunicamycin thymoma viral proto-oncogene 1 Mus musculus